- Report
- April 2022
Nigeria
From €3297EUR$3,750USD£2,847GBP
- Report
- April 2022
Global
From €3385EUR$3,850USD£2,923GBP
- Report
- April 2022
Global
From €3385EUR$3,850USD£2,923GBP
- Report
- April 2022
Global
From €3034EUR$3,450USD£2,620GBP
- Report
- April 2022
Global
From €3385EUR$3,850USD£2,923GBP
- Report
- January 2022
Middle East
From €8353EUR$9,500USD£7,214GBP
- Report
- November 2021
Italy
From €3077EUR$3,500USD£2,658GBP
- Report
- November 2021
Japan
From €3077EUR$3,500USD£2,658GBP
- Report
- November 2021
Asia Pacific
From €12750EUR$14,500USD£11,010GBP
- Report
- November 2021
Spain
From €3077EUR$3,500USD£2,658GBP
- Report
- November 2021
Europe
From €21542EUR$24,500USD£18,604GBP
- Report
- November 2021
United Kingdom
From €3077EUR$3,500USD£2,658GBP
- Report
- November 2021
Latin America
From €12750EUR$14,500USD£11,010GBP
- Report
- November 2021
United States
From €3077EUR$3,500USD£2,658GBP
- Report
- November 2021
Germany
From €3077EUR$3,500USD£2,658GBP
- Report
- November 2021
France, Germany, ... France, Germany, Italy, Spain, United Kingdom, Europe
From €12750EUR$14,500USD£11,010GBP
- Report
- November 2021
Japan, United States, ... Japan, United States, Europe, Global
From €21542EUR$24,500USD£18,604GBP
- Report
- November 2021
Canada, Mexico, North America Canada, Mexico, North America
From €8353EUR$9,500USD£7,214GBP
- Report
- November 2021
France
From €3077EUR$3,500USD£2,658GBP
- Report
- November 2021
Middle East
From €8353EUR$9,500USD£7,214GBP

The Biomarkers market is a sector of the healthcare industry that focuses on the development and use of biomarkers for the diagnosis, prognosis, and treatment of diseases. Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, or to monitor the progression of a disease. They can also be used to predict the response to a particular treatment. Biomarkers are typically proteins, nucleic acids, or metabolites that are found in the body and can be measured in a variety of ways.
Biomarkers are used in a variety of medical applications, including cancer diagnosis and treatment, cardiovascular disease, and neurological disorders. They are also used in drug development, to identify potential drug targets and to monitor the safety and efficacy of drugs.
Some of the major companies in the Biomarkers market include Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche, and Sanofi. Show Less Read more